It is a good question to ask when and if they will obtain a peer reviewed publication of the PDD trial results. That is a goal, not a promise. Apparently, it is not that simple, or it would be completed.
It is a science question and not something that Missling can just snap his fingers and make happen. I suspect he needs some information from the upcoming imaging study to show target engagement in PDD or possibly to enhance the evidence of efficacy with imaging.
You raise a good and valid issue to ask about, but it is a scientific question, not a management one, IMO. For, now, the top line results in PDD must stand on their own until more is shown. The AVXL "platform" is still in tenetive territory and that is why the PPS is not over $100, LOL. IMO, however, the MC now is really way too low due to the press of world events having nothing to do with any of the AVXL clinical trials.
Logic says, Missling is not going to leave the PDD indication and he has told us that he will report on it when he has something more to report. So, you will just have to put up with some more waiting or you can sell your stock, IMO. GLTY.
You can also try talking to IR, but I don't expect you will learn much. LOL.
News 
Market Data 
Discover 
